Caricamento...
The reduced form of coagulation factor XI is associated with illness severity and coagulopathy in critically-ill septic patients
BACKGROUND. Coagulation Factor XI (FXI) contributes to the pathobiology of sepsis-associated thrombosis and is a target for new therapeutics. Through cleavage of disulfide bonds, FXI becomes reduced (rFXI), accelerating intrinsic coagulation cascade activation. The role of rFXI in human sepsis has n...
Salvato in:
| Pubblicato in: | J Thromb Thrombolysis |
|---|---|
| Autori principali: | , , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2019
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6393197/ https://ncbi.nlm.nih.gov/pubmed/30600428 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11239-018-1797-9 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|